Tom Wilemon

The study team included, from left, Douglas Johnson, MD, Dan Roden, MD, Javid Moslehi, MD, Joe-Elie Salem, MD, PhD, and Ali Manouchehri, MD.

Study identifies targeted therapy’s cardiac risks

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.

New telehealth initiative aims to enhance cancer care in rural areas

VUMC is leading an effort to improve cancer care in rural areas with a telehealth initiative supported with a $3.3 million grant from the National Cancer Institute.

Jackson named to new VICC advanced practice role

Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.

DNA sequence

Study backs genetic testing for all metastatic breast cancer patients

Fashion event to help support ovarian cancer research

Vanderbilt Health physicians will be among the runway models during the 7th Annual T.J. Martell Foundation Chic Awearness on Sept. 23.

Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

1 20 21 22 23 24 37